With the MHRA becoming the standalone regulator of medicines in Great Britain, Precision research aims to shed light on market access in the post-Brexit era, as well as key implications for manufacturers. In this Access90, Precision’s Katherine Ka Wan Leong discusses two research posters the PRECISION team will be presenting at ISPOR US this year focusing on the UK access landscape.

Watch the video HERE!